Edition:
United Kingdom

Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

266.94USD
4:24pm BST
Change (% chg)

$2.77 (+1.05%)
Prev Close
$264.17
Open
$265.65
Day's High
$266.94
Day's Low
$264.58
Volume
32,748
Avg. Vol
353,211
52-wk High
$266.94
52-wk Low
$179.44

Summary

Name Age Since Current Position

Elizabeth Tallett

68 2018 Chairman of the Board

Gail Boudreaux

57 2017 President, Chief Executive Officer, Director

John Gallina

58 2016 Chief Financial Officer, Executive Vice President

Prakash Patel

2018 Executive Vice President and President, Diversified Business Group

Jacquelyn Wolf

56 2017 Chief Human Resource Officer, Executive Vice President

Gloria McCarthy

65 2017 Executive Vice President, Chief Administrative Officer, Chief Transformation Officer

Thomas Zielinski

67 2014 Executive Vice President, General Counsel

Peter Haytaian

48 2018 Executive Vice President, President of Commercial and Specialty Business Division

Felicia Norwood

2018 Executive Vice President

Ronald Penczek

53 2015 Senior Vice President, Chief Accounting Officer, Controller

Craig Samitt

53 2018 Chief Chief Clinical Officer

R. Kerry Clark

65 2014 Independent Director

Robert Dixon

62 2011 Independent Director

Lewis Hay

62 2014 Independent Director

Julie Hill

71 2004 Independent Director

Bahija Jallal

56 2018 Independent Director

Antonio Neri

50 2017 Independent Director

Ramiro Peru

62 2004 Independent Director

George Schaefer

72 2018 Independent Director

Will Feest

2016 Senior Director Investor Relations

Biographies

Name Description

Elizabeth Tallett

Ms. Elizabeth E. Tallett is Chairman of the Board of Anthem, Inc., effective May 16, 2018. She has been a director of the Company since October 2013. She was a principal of Hunter Partners, LLC (health care consulting) from June 2002 to February 2015. Ms. Tallett continues to operate as a consultant to health care companies. Previously, Ms. Tallett was President and Chief Executive Officer of Transcell Technologies, Inc. (specialty pharmaceuticals), President of Centocor Pharmaceuticals (biotechnology), member of the Parke-Davis (pharmaceuticals) Executive Committee and Director of Worldwide Strategic Planning for Warner-Lambert Company (pharmaceuticals). Ms. Tallett has served as a director of Meredith Corporation (magazine publisher) since 2008, Principal Financial Group, Inc. (financial services) since 1992 (as presiding director since 2007) and Qiagen, N.V. (biotechnology research equipment manufacturing) since 2011. She previously served as a director of Coventry Health Care, Inc. (health insurance) from 1998 to 2013 (including serving as lead director) and IntegraMed America, Inc. (outpatient health clinics) from 1998 to 2012. Ms. Tallett brings significant CEO, finance, health care industry, insurance industry and marketing and public relations experience to the Board from her chief executive, other management and board positions in several health care, insurance and pharmaceutical organizations. These positions also provided her with regulatory and governmental experience due to the highly regulated nature of these organizations. She also has environmental, social and governance experience, having served as a presiding or lead director and as a member of the governance committees of several public companies.

Gail Boudreaux

Ms. Gail K. Boudreaux is President, Chief Executive Officer, Director of the Company effective November 20, 2017. Prior to joining the Company, she served as Chief Executive Officer of GKB Global Health, LLC (health care strategy and business advisory firm) from July 2015 to November 2017. Prior thereto, Ms. Boudreaux was Executive Vice President of UnitedHealth Group Incorporated (diversified health care company) from May 2008 to February 2015, President of United HealthCare (managed health care company), a subsidiary of UnitedHealth Group Incorporated, from May 2008 to January 2011 and Chief Executive Officer of United HealthCare from January 2011 to November 2014. Before joining United HealthCare, she worked at Health Care Services Corporation (“HCSC”) (health insurance company) as Executive Vice President of External Operations from December 2005 to April 2008 and as President of Blue Cross Blue Shield of Illinois from 2002 to May 2005. Before joining HCSC, Ms. Boudreaux held various positions at Aetna Inc. (managed health care company), including Senior Vice President, Group Insurance. Ms. Boudreaux has served as a director of Zimmer Biomet Holdings, Inc. (medical device company) since 2012. She also serves as a director of the BCBSA, the National Institute for Health Care Management, Health Services Foundation, Dartmouth College Board of Trustees, and the Central Indiana Corporate Partnership, and as a member of the Business Roundtable. She previously served as a director of Xcel Energy, Inc. (utility holding company) from May 2012 to December 2017, Novavax, Inc. (biotechnology company) from June 2015 to November 2017 and Genzyme Corporation (biotechnology company) from 2004 to 2011.

John Gallina

Mr. John E. Gallina is Chief Financial Officer, Executive Vice President of the Company. Mr. Gallina has served as our Executive Vice President and Chief Financial Officer since June 2016. Mr. Gallina joined Anthem in 1994 and has held a variety of leadership roles across the organization. Prior to his current role, Mr. Gallina served as Anthem’s Chief Financial Officer for the Commercial and Specialty Business Division from December 2015 to June 2016, and as Senior Vice President and Chief Accounting Officer from December 2013 to December 2015. Other leadership positions held during his tenure include Senior Vice President, Chief Accounting Officer and Chief Risk Officer from May 2011 to December 2013, while also holding the title of Controller from May 2011 to August 2013. Before joining the Company, Mr. Gallina spent 12 years with Coopers & Lybrand as an Audit Senior Manager.

Prakash Patel

Dr. Prakash Patel M.D. is appointed as Executive Vice President and President, Diversified Business Group of the company effective August 6, 2018. He has more than 23 years of experience across a broad scope of healthcare disciplines, including pharmaceutical, managed care, strategy, corporate development, operations and clinical services experience, including complex care management. He is a strong leader who has been recognized for his ability to both shape and grow organizations through a combination of strategic vision and strong operational expertise. Dr. Patel currently serves as Chief Operating Officer of the GuideWell Enterprise and Florida Blue, as well as President of GuideWell Health. Prior to his current role, he served as Chief Executive Officer of Access Mediquip and has held executive roles with Magellan Health Services, Internet Healthcare Group, and Scheer & Company. Dr. Patel earned his Bachelor of Science degree in anthropology and zoology from the University of Michigan and his Medical Doctorate degree from Cornell University Medical College.

Jacquelyn Wolf

Ms. Jacquelyn H. Wolf is Chief Human Resource Officer, Executive Vice President of the Company. Most recently, Ms. Wolf served as Senior Vice President and Chief Human Resources Officer for LyondellBasell, one of the largest plastics and refining companies in the world. Ms. Wolf has also served as Senior Vice President, Human Resources for Celanese Corporation and as Executive Vice President, Chief Human Resources Officer for Comerica. Prior the these roles, Ms. Wolf served as Global Human Resources Director for General Motors Finance, Asset Management, and Economic Development and Enterprise Services organizations and as Vice President, Human Resources for Honeywell International, Aerospace, Truck Brakes and Avionics segments. Ms. Wolf began her career at General Electric, where she worked in a number of human resources management and labor relations roles supporting GE Capital, Retailer Financial Services, GE Appliance, and GE Lighting. Ms. Wolf received her Bachelor of Arts degree in organizational communications from Youngstown State University in Ohio, a Master of Science, Business Management & Administration from Baker University in Kansas, and a Doctorate in Human and Organizational Systems and Master of Arts in Human & Organizational Systems from Fielding Graduate University in Santa Barbara, California.

Gloria McCarthy

Ms. Gloria M. McCarthy is Executive Vice President, Chief Administrative Officer, Chief Transformation Officer of the Company. She served as our Chief of Staff from August 2016 to December 2017. In addition, Ms. McCarthy assumed oversight for our Medicaid business effective March 2018. She was Executive Vice President of Enterprise Execution and Efficiency from 2012 to 2013. Prior to that appointment, she served as Executive Vice President, Office of the CEO from February 2012 to October 2012, as Senior Vice President for Operational Excellence from 2008 to February 2012, as Senior Vice President of Service Operations from 2006 to 2008 and as Senior Vice President and Chief Operating Officer of our East Region from 2005 to 2006. Prior to our acquisition of WellChoice, Inc. (“WellChoice”) in 2005, Ms. McCarthy served as Executive Vice President and Chief Operating Officer of WellChoice.

Thomas Zielinski

Mr. Thomas C. Zielinski is an Executive Vice President, General Counsel of Anthem, Inc. Mr. Zielinski has served as our Executive Vice President and General Counsel since June 2014, and as Interim General Counsel from February 2014 to June 2014. Prior to joining us, Mr. Zielinski was a partner in the law firm of Morgan Lewis & Bockius, LLP since 2013. He served as Executive Vice President and General Counsel of Coventry Health Care, Inc. (Coventry) (health insurance) from 2007 to 2013 and as Senior Vice President and General Counsel from 2001 to 2007. Prior to joining Coventry, Mr. Zielinski spent 19 years at the law firm of Cozen & O’Connor, P.C.

Peter Haytaian

Mr. Peter D. Haytaian is Executive Vice President, President of Commercial and Specialty Business Division of the Company. From June 2014 until March 2018, Mr. Haytaian served as our Executive Vice President and President of the Government Business Division. Mr. Haytaian joined the Company in December 2012 with our acquisition of Amerigroup Corporation (“Amerigroup”) and served as President of our Medicaid business from August 2013 until June 2014. From 2005 to 2013, Mr. Haytaian held several leadership positions with Amerigroup, including serving as Chief Executive Officer of the North Region for Amerigroup’s Medicaid business from December 2012 until August 2013. Mr. Haytaian has extensive experience leading Medicare and Medicaid programs with Amerigroup and, prior thereto, with Oxford Health Plans, Inc. (health insurance).

Felicia Norwood

Ms. Felicia Norwood is Executive Vice President, President - Government Business Division of the Company. Ms. Norwood has more than 25 years of healthcare operations, policy and strategy experience. Most recently, she served as the director of Illinois' Department of Healthcare and Family Services, leading a $22 billion agency with responsibility for serving the state's 3.2 million Medicaid beneficiaries and 500,000 families receiving child support services. Prior to her current role, Felicia spent nearly 20 years at Aetna, where she served in a number of leadership roles including President, Mid-America Region; CEO, President and Chief Operating Officer of Aetna's population health management subsidiary ActiveHealth Management Inc.; Head of Aetna Medicaid; National Head of Aetna's Small Group and Individual Market Segments; and President, Aetna Government Health Plans, LLC. Ms. Norwood earned her Bachelor of Arts degree in political science from Valdosta State University in Georgia, Masters of Arts in political science from the University of Wisconsin, Madison, and Juris Doctor from Yale Law School.

Ronald Penczek

Mr. Ronald W. Penczek is Senior Vice President, Chief Accounting Officer, Controller of the Company. He served as our Vice President and Controller from August 2013 to November 2015. Prior to that appointment, Mr. Penczek served as Vice President and Assistant Controller from January 2008 to August 2013 and in various other roles in our finance department from February 2006 until January 2008. Before joining us, Mr. Penczek was a Staff Vice President with CNA Insurance from 2000 to 2005 and had various positions with PricewaterhouseCoopers LLP from 1992 to 2000, including as a Manager.

Craig Samitt

Dr. Craig E. Samitt, M.D., is Chief Chief Clinical Officer of Anthem, Inc. He is no longer Executive Vice President and President of Diversified Business Group effective August 6, 2018. Prior to joining us, Dr. Samitt was a Partner and Global Practice Leader, Health & Life Sciences, for the Oliver Wyman Consulting firm from January 2015 to September 2015; the Executive Vice President and then President and CEO, HealthCare Partners, for Davita Healthcare Partners from 2013 to 2014; and President and CEO of Dean Health Systems, Inc. from 2006 to 2013. Dr. Samitt has been a member of the Board of Directors of the National Committee for Quality Assurance since February 2016.

R. Kerry Clark

Mr. R. Kerry Clark is Independent Director of Anthem, Inc. He has been a director of the Company since May 2014. Mr. Clark served as Chairman and Chief Executive Officer of Cardinal Health, Inc. (health care products and services), until his retirement in 2009. Mr. Clark joined Cardinal Health in April 2006 as President and Chief Executive Officer and became Chairman in November 2007. Prior to joining Cardinal Health, he held various positions at The Procter & Gamble Company (consumer products), including President of P&G Asia; President, Global Market Development and Business Operations; and Vice Chairman of the Board, President Global Family Health. He is a director of Avnet, Inc. (industrial distributors of electronic components, enterprise computer and storage products), General Mills, Inc. (consumer food products) and Textron, Inc. (aircraft, defense, and industrial products). He is also a director of Hauser Private Equity LLC (investment firm) and The Christ Hospital in Cincinnati, Ohio (hospital). Mr. Clark brings to the Board extensive CEO, health care industry and marketing and public relations experience through his positions as Chairman and CEO of a major health care services organization, and as a senior executive at an international consumer products company, where he served in several positions involving marketing, advertising and product development of health care and other consumer products. Also, he has health care experience through his service on a hospital board of directors. Mr. Clark qualifies as an “audit committee financial expert” under the SEC’s rules.

Robert Dixon

Mr. Robert L. Dixon, Jr., is Independent Director of Anthem, Inc. has been a director of the Company since July 2011. Mr. Dixon also has been the owner of The RD Factor, Inc., a digital and information technology consulting business, since December 2016. Mr. Dixon served as Global Chief Information Officer and Senior Vice President of PepsiCo, Inc. (food and beverages) from November 2007 until April 2016 and as Senior Vice President until December 2016. Prior to joining PepsiCo, Mr. Dixon held various positions with The Procter & Gamble Company (consumer household products) since 1977, including Vice President of Global Business Services from 2005 until 2007. Mr. Dixon currently serves on the Georgia Institute of Technology College of Engineering Advisory Board. He previously served on the President’s Advisory Board of the Georgia Institute of Technology and the CIO Advisory Board for International Business Machines Corp. Mr. Dixon has extensive technology experience through his position as Global Chief Information Officer of a large public company and his service on the CIO advisory board for another large public company. He also has significant marketing experiences through his senior positions at two large public companies, both of which have global retail consumer product focus.

Lewis Hay

Mr. Lewis Hay, III, is an Independent Director of Anthem, Inc. Mr. Hay has served as an operating advisor at Clayton, Dubilier & Rice, LLC (private equity investment firm) since September 2013. Mr. Hay retired as Executive Chairman of NextEra Energy, Inc. (“NextEra Energy”) (electricity-related services and renewable energy generator) in December 2013, having served in that position since July 2012. At NextEra Energy, he served as Chief Executive Officer from June 2001 to July 2012, Chairman from January 2002 to July 2012, and President from June 2001 to December 2006. He also served as Chief Executive Officer of Florida Power & Light Company from January 2002 to July 2008. Mr. Hay is a director of Capital One Financial Corporation (financial services) and Harris Corporation (international communications and information technology). Mr. Hay was a director and chairman of both the Institute for Nuclear Power Operations and the Edison Electrical Institute until 2013. He also served on the Board of Business Advisors for the Tepper School of Business at Carnegie Mellon University, and on the Advisory Council of Carnegie Mellon University’s Scott Institute for Energy Innovation until May 2017.

Julie Hill

Ms. Julie A. Hill is Independent Director of Anthem, Inc. She has been a director of the Company since November 2004. Ms. Hill served on the former WellPoint Health Networks Inc. (“WHN”) board of directors from March 1994 until WHN’s merger with us in November 2004. Since December 2002, she has been the owner of The Hill Company (real estate company). From December 1998 to December 2002, Ms. Hill was the President and owner of Hiram-Hill Development Company (residential real estate development firm). Prior thereto, she was the Chairman, President and Chief Executive Officer of Costain Homes, Inc. (home builders), the U.S. division of Costain Group Plc, a London-based company, from 1988 to 1997. Ms. Hill is also a director of the Lord Abbett Family of Mutual Funds (mutual funds) and was a director of Lend Lease, Ltd. (international retail and residential property group) until November 2012. At the University of California at Irvine, she serves on the Paul Merage School of Business Dean’s Advisory Council and Center for Real Estate Advisory Board, the Foundation Board, the Social Ecology School’s Dean’s Leadership Council, the School of Medicine’s Dean’s Advisory Board, the Law School Board, and the Center for Digital Transformation Board. Ms. Hill brings extensive CEO and finance experience to the Board gained through her ownership and management of several companies. She also has significant marketing and public relations experience, having held several positions in sales, marketing, advertising and product development. In addition, Ms. Hill has health care industry and environmental, social and governance experience through her many medical school and other university board positions and service with groups promoting environmental, sustainability and other public policy issues. Further, Ms. Hill qualifies as an “audit committee financial expert” under the SEC’s rules.

Bahija Jallal

Dr. Bahija Jallal is appointed as Independent Director of the company effective February 1, 2018. Ms. Jallal has served as Executive Vice President of AstraZeneca PLC (“AstraZeneca”) (pharmaceutical and biopharmaceutical business) and President of MedImmune (biotechnology business), a subsidiary of AstraZeneca, since January 2013. She joined MedImmune in 2006 and held various research and development positions, including Executive Vice President, Research and Development, from 2010 to 2013. She has been President of the Board of the Association for Women in Science since 2016 and a member of the Board of Trustees of Johns Hopkins University since 2014. Ms. Jallal brings extensive health care industry experience to the Board gained through her several leadership positions at biopharmaceutical companies that provide new medicines to patients, including her current position of Executive Vice President at a multinational pharmaceutical and biopharmaceutical company. In addition, Ms. Jallal has CEO and finance experience through her position of President at a biologic research and development subsidiary of a large public company.

Antonio Neri

Mr. Antonio F. Neri is Independent Director of the Company. He has served as President and Chief Executive Officer of Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”) (technology company) since February 2018. At Hewlett Packard Enterprise, he also served as President from June 2017 to February 2018 and Executive Vice President and General Manager, Enterprise Group from 2015 to June 2017. Prior to Hewlett Packard Enterprise’s spinoff from HP Inc. (technology company), Mr. Neri held a variety of leadership roles at HP Inc. since 1995, including Senior Vice President and General Manager, Enterprise Group from October 2014 to November 2015, Senior Vice President and General Manager, HP Servers from September 2013 to October 2014 and Senior Vice President and General Manager, HP Technology Services from August 2011 to September 2013. Mr. Neri has served as a director of Hewlett Packard Enterprise since February 2018. He was a director of H3C Technologies Co., LTD (information technology company), from May 2016 to July 2017. From March 2012 to February 2013, Mr. Neri was a director of Mphasis Limited (cloud technology company). Mr. Neri has significant technology and marketing and public relations experience, having held several leadership positions at firms that provide technology solutions to the business and public sectors, including his current position of President and CEO of a large, multinational enterprise information technology company. In addition, Mr. Neri brings CEO and finance experience to the Board gained through his positions with Hewlett Packard Enterprise. Further, Mr. Neri qualifies as an “audit committee financial expert” under the SEC’s rules.

Ramiro Peru

Mr. Ramiro G. Peru is Independent Director of Anthem, Inc. He has been a director of the Company since November 2004. Mr. Peru served on the former WHN board of directors from May 2003 until WHN’s merger with us in November 2004. During the second half of 2007, Mr. Peru was Executive Vice President and Chief Financial Officer of Swift Corporation (transportation) and prior thereto was Executive Vice President and Chief Financial Officer of Phelps Dodge Corporation (mining and manufacturing) from 1999 to 2007 (“Phelps Dodge”). Mr. Peru joined Phelps Dodge in 1979 and held various finance and accounting positions with Phelps Dodge and its affiliates. Mr. Peru is also a director of SM Energy Company (oil and gas exploration and production company) and UNS Energy Corporation (an electric and gas utility holding company). Mr. Peru brings significant finance experience to the Board as a former chief financial officer of two public companies. Mr. Peru’s positions also included technology experience as Senior Vice President at Phelps Dodge with responsibility for managing both information systems and technology and human resources. Further, Mr. Peru qualifies as an “audit committee financial expert” under the SEC’s rules.

George Schaefer

Mr. George A. Schaefer, Jr., is Independent Director of Anthem, Inc., effective May 16, 2018. He has been a director of the Company since 2001 and a director of Anthem Insurance Companies, Inc. (“Anthem Insurance”) from 1995 to May 2003. Mr. Schaefer served as Chair of the Board of the Company from May 2013 until December 2015, at which time he was elected to his current role of Lead Director. He served as President and Chief Executive Officer of Fifth Third Bancorp (banking) from 1990 to 2006, as Chairman of the Board and Chief Executive Officer until April 2007, and as Chairman of the Board until June 2008. He is also a director of Ashland Global Holdings Inc. (petroleum and chemical business). He is a board member of the University of Cincinnati Healthcare System (health care system) and the University of Cincinnati Healthcare Foundation. As the former President, CEO and Chairman of a large Midwest bank holding company, Mr. Schaefer brings extensive CEO and finance experience to the Board, as well as marketing and public relations and technology experience from his involvement in retail marketing and product development for the financial institution. Also, he has health care industry experience through his service on the boards of several hospital systems and medical schools. Further, Mr. Schaefer qualifies as an “audit committee financial expert” under the SEC’s rules.

Will Feest